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A new regulatory 
loop in cancer-cell 
invasion
the epithelial-to-mesenchymal transition (EMt) converts epithelial 
cells into mesenchymal cells that are able to invade and migrate. in 
the context of cancer pathogenesis, the EMt contributes to meta-
static progression (thiery, 2002; acloque et al, 2008). one of the 
characteristics of EMt is the functional loss of E-cadherin, which is 
crucial for the progression to invasive carcinoma (perl et al, 1998). 
transcriptional repression has emerged as a fundamental mecha-
nism for E-cadherin loss during EMt and several repressors have 
been characterized. these include zinc-finger E-box-binding homeo-
box 1 (zEB1), zEB2/Sip1, Snail1, Snail2 and twist, which strongly 
repress E-cadherin transcription through their direct binding to the 
E-box motifs within the E-cadherin promoter (Barrallo-gimeno & 
nieto, 2005; peinado et al, 2007). During the past decade, it has 
emerged that micrornas (mirnas) are a fundamental mecha-
nism of gene-expression regulation, and several recent reports 
have shown that these small molecules are involved in the con-
trol of E-cadherin expression in cancer cells and tumours (Hurteau 
et al, 2007; christoffersen et al, 2007; gregory et al, 2008; park 
et al, 2008). Furthermore, in this issue of EMBO reports, Burk and 
colleagues have provided a beautiful example of gene regulation in 
which mirnas and transcription factors are linked to one another 
in a gene-regulatory network to control E-cadherin expression and 
the invasive phenotype in cancer cells (Burk et al, 2008).
Mirnas regulate gene expression through binding to mrna tar-
get sequences typically in their 3' untranslated regulatory regions 
(utrs), which results in the degradation of target mrnas and/or the 
inhibition of the translation process (Filipowicz et al, 2008). Several 
mirnas are deregulated or mutated in many human cancers, 
including lung, breast, brain, liver and colon cancers, making them 
attractive targets in biomedical research and anti-tumour therapies 
(Esquela-Kerscher & Slack, 2006; zhang et al, 2007; couzin, 2008).
Mirnas can function as tumour promoters or as tumour sup-
pressors. For example, mir-10b, mir-373 and mir-520c are highly 
expressed in metastatic breast cancer cells in which they positively 
regulate cell migration, invasion and metastatic properties (Ma 
et al, 2007; Huang et al, 2008). Similarly, mir-21 is increased in 
breast and colon carcinomas and is upregulated during the trans-
forming growth factor-β (tgFβ)-induced EMt in cancer-derived 
cell lines (zavadil et al, 2007). conversely, tavazoie and colleagues 
showed that mir-126, mir-206 and mir-335 suppress breast can-
cer metastasis (tavazoie et al, 2007), and they were able to confirm 
clinical relevance for mir-126 and mir-335. Similarly, let-7 is a 
marker for differentiated cancers and seems to impair tumour pro-
gression by preventing the re-expression of early embryonic genes 
during the initial steps of neoplastic transformation. However, let-7 
is unlikely to be an EMt regulator as its expression cannot be asso-
ciated with changes in the expression of EMt markers (Shell et al, 
2007; park et al, 2007).
given the relevance of both EMt and mirnas in tumour pro-
gression, the question became whether other mirnas had a role in 
the induction of EMt. indeed, two recent reports indicate that the 
EMt inducers zEB1 and zEB2/Sip1 are direct targets of mir-200 
family members, suggesting that mirnas can indirectly regulate 
E-cadherin expression in tumour cell lines (christoffersen et  al, 
2007; Hurteau et al, 2007). two additional comprehensive studies 
have now confirmed that members of the mir-200 family directly 
repress the zEB1 and zEB2/Sip1 factors in a cooperative man-
ner, and that there is a strong correlation between the expression 
of mir-200 and that of E-cadherin in several cancer cell lines and 
human tumours (gregory et al, 2008; park et al, 2008). conversely, 
the expression of the mir-200 family is lost in mesenchymal and 
invasive cells, as it is in poorly differentiated and aggressive meta-
plastic breast cancers. interestingly, the silencing of mir-200 fam-
ily members is sufficient to induce EMt and invasion in epithelial 
cell lines, whereas their overexpression can trigger the reverse 
process—the mesenchymal-to-epithelial transition (MEt; gregory 
et al, 2008; park et al, 2008). these data suggest that the loss of the 
mir-200 family might be crucial for the induction of EMt during 
tumour progression.
once it had been established that the mir-200 family represses 
Zeb gene transcription, and given that several family members are 
lost in invasive carcinomas, Burk and colleagues took one step fur-
ther and asked whether the forced downregulation of zEB1 modi-
fies mirna expression in cancer cells (Fig 1a; Burk et al, 2008). 
they found that the mir-200 family members mirna-200c and 
mirna-141 are upregulated, and that their putative regulatory ele-
ments contain several binding sequences for zEB1, some of which 
can also be recognized by other EMt inducers. indeed, zEB1 directly 
suppresses the transcription of mir-200c and mir-141, giving rise to 
a negative-feedback loop of transcriptional coregulation of mirnas 
and their targets as previously modelled by tsang and colleagues 
(Fig 1B; tsang et  al, 2007). interestingly, mir-141 also represses 
the EMt inducer tgFβ2 (Burk et al, 2008), perhaps reinforcing the 
epithelial state. indeed, the normal epithelial condition is character-
ized by high levels of mir-200 that maintain high E-cadherin levels 
and tissue homeostasis. in cancer cells, the increase in the signals 
that activate Zeb genes and other EMt inducers might overcome this 
control and favour the transition to the mesenchymal state.
the past few months have witnessed the emergence of a plethora 
of studies linking mirnas with tumour invasion and metastasis. a 
tight connection between the mir-200 family and EMt in tumour 
progression has unveiled how transcription factors and mirnas are 
linked to one another in gene-regulatory networks. this network 
might function to maintain epithelial homeostasis or to trigger a zEB1 
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self-enhancing loop of epithelial repression and invasion in cancer 
cells. it will be interesting to determine whether other EMt inducers 
are regulated by the mirna-200 family and whether mirnas are 
able to repress cancer progression in vivo. indeed, the reversibility of 
the EMt process induced by mir-200 overexpression provides some 
hope for the use of mirnas as therapeutic anti-invasive drugs.
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Fig 1 | Schematic representation of the regulatory loop between the miR-200 
family and ZEB factors. (A) Various cellular states are characterized by the 
relative activity of Zeb genes and members of the miR-200 family. The epithelial 
cell expresses high levels of miR-200 and E-cadherin, whereas the mesenchymal 
cell expresses high levels of ZEB and vimentin. Active genes are shown in 
black and inactive genes in grey (adapted from Gregory et al, 2008; Park et al, 
2008 and Burk et al, 2008). (B) The two cellular states can be two outcomes 
of a circuit in which a signal (in this case S = TGFβ) induces the expression of 
transcription factors (in this case TF = ZEB factors). These transcription factors 
are the targets of the microRNAs (miRNAs) that they repress (in this case the 
miR-200 family), generating a negative-feedback loop (see Tsang et al, 2007 for 
coordinated transcriptional and miRNA-mediated regulatory models). The 
miRNA negatively regulates not only the expression of the TFs but also the 
expression of the signal (TGFβ). EMT, epithelial-to-mesenchymal transition; 
MET, mesenchymal-to-epithelial transition; SIP1, Smad interacting protein 1; 
TGFβ, transforming growth factor-β; ZEB, zinc-finger E-box-binding 
homeobox transcription factors.
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